The prognostic value of immune checkpoints in oral squamous cell carcinoma-Reference-Cited by-同舟云学术

The prognostic value of immune checkpoints in oral squamous cell carcinoma

Published:2018-11-12 Issue:6 Volume:25 Page:1435-1445
ISSN:1354-523X
Container-title:Oral Diseases
language:en
Short-container-title:Oral Dis

Author:

Sieviläinen Meri¹^ORCID,Almahmoudi Rabeia¹,Al‐Samadi Ahmed¹,Salo Tuula¹²³,Pirinen Matti⁴⁵⁶,Almangush Alhadi¹⁷⁸

Affiliation:

1. Department of Oral and Maxillofacial Diseases, Clinicum University of Helsinki Helsinki Finland

2. Medical Research Centre Oulu University Hospital Oulu Finland

3. Department of Diagnostics and Oral Medicine, Medical Faculty, Research Group of Cancer Research and Translational Medicine University of Oulu Oulu Finland

4. Institute for Molecular Medicine Finland FIMM, Helsinki Institute of Life Science HiLIFE University of Helsinki Helsinki Finland

5. Department of Public Health University of Helsinki Helsinki Finland

6. Department of Mathematics and Statistics University of Helsinki Helsinki Finland

7. Department of Pathology University of Helsinki Helsinki Finland

8. Institute of Dentistry University of Misurata Misurata Libya

Funder

the Cancer Society of Finland

the Sigrid Jusélius Foundation

the Oulu University Hospital MRC grant

Helsingin seudun hammaslääkärit

the Academy of Finland

Eteläsuomalaisten ylioppilaiden säätiö

the Emil Aaltonen Foundation

the Helsinki University Central Hospital research funds

the Finnish Dental Society

Publisher

Wiley

Subject

General Dentistry,Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/odi.12991

Reference42 articles.

1. Clinicopathologic implications of the miR-197/PD-L1 axis in oral squamous cell carcinoma

2. Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis

3. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration

4. Glycoprotein B7-H3 overexpression and aberrant glycosylation in oral cancer and immune response

5. Associations among pretreatment tumor necrosis and the expression of HIF-1α and PD-L1 in advanced oral squamous cell carcinoma and the prognostic impact thereof

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive study on the prognostic value and clinicopathological significance of different immune checkpoints in patients with colorectal cancer: a systematic review and meta-analysis;Current Therapeutic Research;2024-09

2. MRI tumour volumetry as a new staging tool in diagnosis and therapy of oral cancer;Journal of Cranio-Maxillofacial Surgery;2024-08

3. Inhibition of Bioactive Compounds Against “FimA” of Porphyromonas gingivalis and “FadA” of Fusobacterium nucleatum Associated with OSCC;Proceedings of the National Academy of Sciences, India Section B: Biological Sciences;2024-06-14

4. Water-soluble 4-(dimethylaminomethyl)heliomycin exerts greater antitumor effects than parental heliomycin by targeting the tNOX-SIRT1 axis and apoptosis in oral cancer cells;eLife;2024-04-03

5. Immunotherapy: The Fourth Domain in Oral Cancer Therapeutics;Indian Journal of Otolaryngology and Head & Neck Surgery;2024-03-10